100 Odcinki

  1. Key Factors for Choosing the Right CDMO

    Opublikowany: 28.08.2023

  2. Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

    Opublikowany: 21.08.2023

  3. Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

    Opublikowany: 15.08.2023

  4. Drug Patent Reports now available on Amazon

    Opublikowany: 14.08.2023

  5. Artificial Intelligence and Machine Learning in Drug Discovery and Development

    Opublikowany: 10.08.2023

  6. Prevalence and timing of authorized generics in the US market

    Opublikowany: 8.08.2023

  7. Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

    Opublikowany: 7.08.2023

  8. The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

    Opublikowany: 5.08.2023

  9. Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

    Opublikowany: 2.08.2023

  10. Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

    Opublikowany: 28.07.2023

  11. DrugPatentWatch reveals NIH funding for patents

    Opublikowany: 27.07.2023

  12. Filing Strategies for Maximizing Pharma Patents

    Opublikowany: 25.07.2023

  13. DrugChatter Featured Questions

    Opublikowany: 8.06.2023

  14. DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

    Opublikowany: 22.05.2023

  15. NPR and DrugPatentWatch – Can drug injector pens be swapped?

    Opublikowany: 16.05.2023

  16. Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

    Opublikowany: 19.04.2023

  17. Social Return on Investment

    Opublikowany: 6.09.2022

  18. CDCDB: A large and continuously updated drug combination database

    Opublikowany: 7.06.2022

  19. DrugPatentWatch named “Best of the Web” by Genetic Engineering News

    Opublikowany: 2.05.2022

  20. The value of method of use patent claims in protecting your therapeutic assets

    Opublikowany: 5.04.2022

3 / 5

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management

Visit the podcast's native language site